Non-Billable / Non-Specific Code
ICD-10-CM C94 is the diagnosis code for Other leukemias of specified cell type. This code falls under the section "Malignant neoplasms of lymphoid, hematopoietic and related tissue" within Chapter 2 — Neoplasms (C00-D49). It is a non-billable/non-specific ICD-10-CM code that should not be used for reimbursement. A more specific sub-code is required for billing. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
The following conditions should never be coded at the same time as C94. They are mutually exclusive:
Understanding where C94 sits in the ICD-10-CM classification helps ensure proper coding:
No, C94 is a non-billable/non-specific code. You should use a more specific sub-code for billing and reimbursement.
C94 is the ICD-10-CM diagnosis code for "Other leukemias of specified cell type". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
C94 is located in Section C81-C96 — "Malignant neoplasms of lymphoid, hematopoietic and related tissue" within Chapter 2 of the ICD-10-CM Tabular List.
C94 has 6 sub-code(s) that provide more specific detail: C94.0, C94.2, C94.3, C94.4, C94.6 and more.
Use C94 when the patients documented diagnosis matches "Other leukemias of specified cell type" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Other leukemias of specified cell type is C94.
No, C94 is non-billable. Use a more specific sub-code for primary diagnosis billing.
C94 is in Chapter 2 of the ICD-10-CM Tabular List.
Type 1 Excludes for C94 include: leukemic reticuloendotheliosis (C91.4-); myelodysplastic syndromes (D46.-); personal history of leukemia (Z85.6) and more.
Yes, C94 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.